We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+4.39%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$5.74B
AUM Growth
+$541M
(+10%)
Cap. Flow
+$368M
Cap. Flow
% of AUM
6.41%
Top 10 Holdings %
Top 10 Hldgs %
14.68%
Holding
2,530
New
949
Increased
622
Reduced
470
Closed
486
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$203M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$91.1M |
| 3 |
PG&E
PCG
|
+$57.7M |
| 4 |
VanEck Gold Miners ETF
GDX
|
+$53.7M |
| 5 |
Boston Scientific
BSX
|
+$41.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Japan ETF
EWJ
|
+$67M |
| 2 |
iShares MSCI India ETF
INDA
|
+$55.1M |
| 3 |
Apple
AAPL
|
+$50.9M |
| 4 |
Intuit
INTU
|
+$43.3M |
| 5 |
Lowe's Companies
LOW
|
+$41.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 13.3% |
| 2 | Technology | 11.38% |
| 3 | Healthcare | 10.73% |
| 4 | Industrials | 10.27% |
| 5 | Financials | 8.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1201
Kadant
KAI
$3.69B
| $508K | 0.01% |
5,057
+2,557
| +102% | +$260K |
|
1202
Impinj
PI
$3.89B
| $506K | 0.01% |
22,470
+15,621
| +228% | +$448K |
|
|
CYS
1203
DELISTED
CYS Investments Inc.
CYS
| $506K | 0.01% |
62,998
+19,209
| +44% | +$159K |
|
|
DBD
1204
DELISTED
Diebold Nixdorf Incorporated
DBD
| $505K | 0.01% |
+30,858
| New | +$597K |
|
|
CTB
1205
DELISTED
Cooper Tire & Rubber Co.
CTB
| $505K | 0.01% |
+14,291
| New | +$505K |
|
1206
Malibu Boats
MBUU
$544M
| $504K | 0.01% |
+16,954
| New | +$517K |
|
1207
iShares MSCI South Korea ETF
EWY
$21.7B
| $501K | 0.01% |
6,681
-263,995
| -98% | -$19.5M |
|
1208
Xencor
XNCR
$1.44B
| $501K | 0.01% |
+22,867
| New | +$496K |
|
|
NEX
1209
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $501K | 0.01% |
+26,356
| New | +$413K |
|
1210
Employers Holdings
EIG
$908M
| $500K | 0.01% |
+11,266
| New | +$531K |
|
1211
InterDigital
IDCC
$6.68B
| $500K | 0.01% |
6,568
-37,170
| -85% | -$2.78M |
|
|
UMPQ
1212
DELISTED
Umpqua Holdings Corp
UMPQ
| $500K | 0.01% |
24,042
-66,856
| -74% | -$1.38M |
|
|
SIOX
1213
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $499K | 0.01% |
+11,825
| New | +$531K |
|
1214
iShares MSCI Australia ETF
EWA
$1.34B
| $498K | 0.01% |
+21,500
| New | +$491K |
|
|
SHYF
1215
DELISTED
The Shyft Group
SHYF
| $498K | 0.01% |
31,639
+20,119
| +175% | +$306K |
|
|
CNCE
1216
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $498K | 0.01% |
19,263
-2,237
| -10% | -$45K |
|
1217
Oxford Industries
OXM
$577M
| $495K | 0.01% |
6,579
-3,302
| -33% | -$221K |
|
|
ZVO
1218
DELISTED
Zovio Inc. Common Stock
ZVO
| $494K | 0.01% |
59,494
+32,269
| +119% | +$299K |
|
|
PRFT
1219
DELISTED
Perficient Inc
PRFT
| $493K | 0.01% |
+25,842
| New | +$500K |
|
1220
Abercrombie & Fitch
ANF
$4.17B
| $492K | 0.01% |
28,227
+11,417
| +68% | +$173K |
|
1221
Madison Square Garden
MSGS
$9.54B
| $492K | 0.01% |
3,274
+1,090
| +50% | +$168K |
|
1222
CACI
CACI
$10.8B
| $491K | 0.01% |
3,708
-4,128
| -53% | -$557K |
|
1223
Cimpress
CMPR
$2.37B
| $489K | 0.01% |
+4,081
| New | +$468K |
|
1224
PTC Therapeutics
PTCT
$6.37B
| $489K | 0.01% |
+29,337
| New | +$497K |
|
1225
Central Pacific Financial
CPF
$997M
| $488K | 0.01% |
16,365
+9,273
| +131% | +$289K |
|
Similar funds
Squarepoint's Q4 2017 Portfolio in Review
As of Q4 2017, Squarepoint held 2,530 positions worth $5.74B, up 10% from $5.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Squarepoint deployed $368M of net new capital in Q4 2017, opening 949 new positions and adding to 622 existing holdings. Its largest new stake was Boston Scientific: 1,494,796 shares worth $37.1M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 13% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $50.9M trimmed.
- Squarepoint's largest Q4 2017 buy was Boston Scientific: 1,494,796 shares worth $37.1M.
- Squarepoint added most to iShares Core MSCI Emerging Markets ETF in Q4 2017, an estimated $203M increase.
- Squarepoint's biggest Q4 2017 reduction was Apple, cutting an estimated $50.9M.
- Squarepoint fully exited iShares MSCI Japan ETF in Q4 2017, selling an estimated $67M.
- Squarepoint's ten largest holdings make up 15% of its $5.74B portfolio in Q4 2017.
- Squarepoint opened 949 new positions and closed 486 in Q4 2017.
- Squarepoint's portfolio value rose 10% quarter-over-quarter to $5.74B.
Based on Squarepoint's 13F filing for Q4 2017, filed 14 Feb 2018.